MINNEAPOLIS--(BUSINESS WIRE)--Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic (NYSE: MDT), Inc., today announced the U.S. market launch of the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which makes minimally-invasive treatment of thoracic aortic aneurysms easier to perform.
